HER2 expression and efficacy of T-DM1

by Montemurro, Filippo
Published in Breast Cancer Res (2014)

Does immediate reconstruction increase postmastectomy surgical site infection?

by Carlucci, Salvatore, Montemurro, Filippo, Ponzone, Riccardo
Published 2012

Potential of afatinib in the treatment of patients with HER2-positive breast cancer

by Geuna, Elena, Montemurro, Filippo, Aglietta, Massimo, Valabrega, Giorgio
Published 2012

Role of trastuzumab in the management of HER2-positive metastatic breast cancer

by Milani, Andrea, Montemurro, Filippo, Gioeni, Luisa, Aglietta, Massimo, Valabrega, Giorgio
Published 2010

The Clinical Efficacy and Safety of Neratinib in Combination with Capecitabine for the Treatment of Adult Patients with Advanced or Metastatic HER2-Positive Breast Cancer

by Chilà, Giovanna, Guarini, Vincenzo, Galizia, Danilo, Geuna, Elena, Montemurro, Filippo
Published in Drug Des Devel Ther (2021)

Clinical utility of exemestane in the treatment of breast cancer

by Zucchini, Giorgia, Geuna, Elena, Milani, Andrea, Aversa, Caterina, Martinello, Rossella, Montemurro, Filippo
Published in Int J Womens Health (2015)

A computer-aided diagnosis (CAD) scheme for pretreatment prediction of pathological response to neoadjuvant therapy using dynamic contrast-enhanced MRI texture features

by Giannini, Valentina, Mazzetti, Simone, Marmo, Agnese, Montemurro, Filippo, Regge, Daniele, Martincich, Laura
Published in Br J Radiol (2017)

AKT signaling in ERBB2-amplified breast cancer

by Carmona, F Javier, Montemurro, Filippo, Kannan, Srinivasaraghavan, Rossi, Valentina, Verma, Chandra, Baselga, José, Scaltriti, Maurizio
Published in Pharmacol Ther (2015)

Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM)

by Di Maio, Massimo, Bruzzi, Paolo, Perrone, Francesco, Torri, Valter, Montemurro, Filippo, Tiseo, Marcello, Vasile, Enrico
Published in ESMO Open (2016)

Trastuzumab Beyond Progression in Retrospective Analyses: An Issue of Equal Opportunities

by Montemurro, Filippo, Redana, Stefania, Geuna, Elena, Milani, Andrea, Rossi, Valentina, Martinello, Rossella, Valabrega, Giorgio, Aglietta, Massimo
Published 2011

“Metastatic Cancer of Unknown Primary” or “Primary Metastatic Cancer”?

by Kolling, Stefan, Ventre, Ferdinando, Geuna, Elena, Milan, Melissa, Pisacane, Alberto, Boccaccio, Carla, Sapino, Anna, Montemurro, Filippo
Published in Front Oncol (2020)

Vinorelbine-based salvage therapy in HER2-positive metastatic breast cancer patients progressing during trastuzumab-containing regimens: a retrospective study

by Montemurro, Filippo, Redana, Stefania, Nolè, Franco, Donadio, Michela, Jacomuzzzi, Maria Elena, Valabrega, Giorgio, Viale, Giuseppe, Sapino, Anna, Aglietta, Massimo
Published 2008

A pilot study evaluating serum pro-prostate-specific antigen in patients with rising PSA following radical prostatectomy

by Sottile, Antonino, Ortega, Cinzia, Berruti, Alfredo, Mangioni, Monica, Saponaro, Sara, Polo, Alessandra, Prati, Veronica, Muto, Giovanni, Aglietta, Massimo, Montemurro, Filippo
Published 2012

Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison

by Redana, Stefania, Donadio, Michela, Nolè, Franco, Jacomuzzi, Maria Elena, Beano, Alessandra, Martinello, Rossella, Sapino, Anna, Viale, Giuseppe, Aglietta, Massimo, Montemurro, Filippo
Published 2010

Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer

by Peraldo-Neia, Caterina, Migliardi, Giorgia, Mello-Grand, Maurizia, Montemurro, Filippo, Segir, Raffaella, Pignochino, Ymera, Cavalloni, Giuliana, Torchio, Bruno, Mosso, Luciano, Chiorino, Giovanna, Aglietta, Massimo
Published 2011

Moderate Immunohistochemical Expression of HER-2 (2+) Without HER-2 Gene Amplification Is a Negative Prognostic Factor in Early Breast Cancer

by Rossi, Valentina, Sarotto, Ivana, Maggiorotto, Furio, Berchialla, Paola, Kubatzki, Franziska, Tomasi, Nicoletta, Redana, Stefania, Martinello, Rossella, Valabrega, Giorgio, Aglietta, Massimo, Ponzone, Riccardo, Montemurro, Filippo
Published 2012

Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases

by Siravegna, Giulia, Geuna, Elena, Mussolin, Benedetta, Crisafulli, Giovanni, Bartolini, Alice, Galizia, Danilo, Casorzo, Laura, Sarotto, Ivana, Scaltriti, Maurizio, Sapino, Anna, Bardelli, Alberto, Montemurro, Filippo
Published in ESMO Open (2017)

Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report

by Benvenuti, Silvia, Milan, Melissa, Geuna, Elena, Pisacane, Alberto, Senetta, Rebecca, Gambardella, Gennaro, Stella, Giulia M, Montemurro, Filippo, Sapino, Anna, Boccaccio, Carla, Comoglio, Paolo M
Published in EMBO Mol Med (2020)

Potential biomarkers of long‐term benefit from single‐agent trastuzumab or lapatinib in HER2‐positive metastatic breast cancer

by Montemurro, Filippo, Prat, Aleix, Rossi, Valentina, Valabrega, Giorgio, Sperinde, Jeff, Peraldo-Neia, Caterina, Donadio, Michela, Galván, Patricia, Sapino, Anna, Aglietta, Massimo, Baselga, José, Scaltriti, Maurizio
Published in Mol Oncol (2013)

Treatment with Beta-Blockers and ACE-Inhibitors in Breast Cancer Patients Receiving Adjuvant Trastuzumab-Based Therapy and Developing Mild Cardiac Toxicity: A Prospective Study

by Geuna, Elena, Lombardi, Pasquale, Martinello, Rossella, Garino, Davide, Bonzano, Alessandro, Galizia, Danilo, Nuzzo, Annamaria, Berchialla, Paola, Becco, Paolo, Mangioni, Monica, De Zarlo, Lorena, Montemurro, Filippo
Published in Cancers (Basel) (2020)